BOSTON ADVISORS LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
BOSTON ADVISORS LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,367,000
+48.3%
73,869
+49.0%
0.07%
+44.9%
Q2 2019$922,000
-72.0%
49,576
-63.2%
0.05%
-70.8%
Q1 2019$3,288,000
+412.1%
134,559
+443.9%
0.17%
+354.1%
Q4 2018$642,000
-8.4%
24,740
+11.7%
0.04%
+23.3%
Q3 2018$701,000
-5.5%
22,145
+15.9%
0.03%
+57.9%
Q2 2018$742,000
-2.8%
19,105
-30.9%
0.02%
-5.0%
Q1 2018$763,00027,6550.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders